Showing results (171-180 of 187) with videos related to
Sort By:
Pageof 19
Glycobiology|March 10, 2020
Quantitative analysis of serum-based IgG agalactosylation for tuberculosis auxiliary diagnosisPeng Liu, Shifang Ren, Yan Xie, et al.Plos One|March 22, 2013
Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinomaLin Chen, Haiou Liu, Jing Liu, et al.Clinical Rheumatology|August 7, 2020
Correction to: The IgG galactosylation ratio is higher in spondyloarthritis patients and associated with the MRI scoreJing Liu, Qi Zhu, Jing Han, et al.Clinical Rheumatology|March 4, 2020
The IgG galactosylation ratio is higher in spondyloarthritis patients and associated with the MRI scoreJing Liu, Qi Zhu, Jing Han, et al.Journal of Medicinal Chemistry|November 26, 2009
Hybrid inhibitors of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR): design, synthesis, and superior antitumor activity of novel wortmannin-rapamycin conjugatesSemiramis Ayral-Kaloustian, Jianxin Gu, Judy Lucas, et al.International Journal of Molecular Sciences|October 1, 2016
Elevated Expression of Calpain-4 Predicts Poor Prognosis in Patients with Gastric Cancer after GastrectomyPeike Peng, Lingqiang Min, Shushu Song, et al.Cancer Science|October 31, 2012
Clinical and prognostic implications of β1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancerXuefei Wang, Hongyong He, Heng Zhang, et al.Journal of Medicinal Chemistry|February 17, 2006
Pegylated wortmannin and 17-hydroxywortmannin conjugates as phosphoinositide 3-kinase inhibitors active in human tumor xenograft modelsTianmin Zhu, Jianxin Gu, Ker Yu, et al.Oncotarget|February 11, 2017
High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinomaLili Li, Miaomiao Shao, Peike Peng, et al.Scientific Reports|July 13, 2016
Decreased expression of Calpain-9 predicts unfavorable prognosis in patients with gastric cancerPeike Peng, Weicheng Wu, Junjie Zhao, et al.Pageof 19